In a research report issued to investors today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Natus Medical (NASDAQ:BABY) and slightly …
In a research report issued today, Roth Capital analyst Chris Lewis assigned a Buy rating on Align Technology (NASDAQ:ALGN) with a price target …
In a research report issued today, Roth Capital analyst Chris Lewis assigned a Buy rating on Natus Medical (NASDAQ:BABY) with a price target …
In a research report released Friday, Roth Capital analyst Chris Lewis reiterated a Buy rating on Exact Sciences (NASDAQ:EXAS) and raised his price target to …
In a research report released Friday, Roth Capital analyst Chris Lewis assigned a Buy rating on Masimo Corp. (NASDAQ:MASI) with a $29 price target, following …
In a research report issued today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Volcano (NASDAQ:VOLC) with a price target of …
In a research report issued today, Roth Capital analyst Chris Lewis maintained a Buy rating on Enteromedics (NASDAQ:ETRM) with a $5 price target, following today’s …
In a research note released earlier today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Tearlab (NASDAQ:TEAR) with an $8 price target, following TEAR’s …
In a research note published today, Roth Capital analyst Chris Lewis reiterated a Buy rating on TearLab Corporation (NASDAQ:TEAR) with an $8 price target, …
In a research note published today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Natus Medical (NASDAQ:BABY) with a $33 price …